Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners.

Iaccarino L, Talarico R, Bozzalla-Cassione E, Burmester GR, Culver EL, Doria A, Ebbo M, van Hagen PM, Hachulla E, van Laar JAM, Lanzillotta M, Martinez-Valle F, Montecucco C, Monti S, Nalli C, Schleinitz N, Tincani A, Della-Torre E, Alexander T

Open source

DOI: 10.55563/clinexprheumatol/qq9qup
Published: 2022 May
Container: Clinical and experimental rheumatology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.55563/clinexprheumatol/qq9qup,
  title = {Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners.},
  author = {Iaccarino L and Talarico R and Bozzalla-Cassione E and Burmester GR and Culver EL and Doria A and Ebbo M and van Hagen PM and Hachulla E and van Laar JAM and Lanzillotta M and Martinez-Valle F and Montecucco C and Monti S and Nalli C and Schleinitz N and Tincani A and Della-Torre E and Alexander T},
  year = {2022},
  journal = {Clinical and experimental rheumatology},
  doi = {10.55563/clinexprheumatol/qq9qup},
  url = {https://doi.org/10.55563/clinexprheumatol/qq9qup}
}

RIS

TY  - JOUR
TI  - Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners.
AU  - Iaccarino L
AU  - Talarico R
AU  - Bozzalla-Cassione E
AU  - Burmester GR
AU  - Culver EL
AU  - Doria A
AU  - Ebbo M
AU  - van Hagen PM
AU  - Hachulla E
AU  - van Laar JAM
AU  - Lanzillotta M
AU  - Martinez-Valle F
AU  - Montecucco C
AU  - Monti S
AU  - Nalli C
AU  - Schleinitz N
AU  - Tincani A
AU  - Della-Torre E
AU  - Alexander T
PY  - 2022
JO  - Clinical and experimental rheumatology
DO  - 10.55563/clinexprheumatol/qq9qup
UR  - https://doi.org/10.55563/clinexprheumatol/qq9qup
ER  -

APA

L, I., R, T., E, B., GR, B., EL, C., A, D., M, E., PM, V. H., E, H., JAM, V. L., M, L., F, M., C, M., S, M., C, N., N, S., A, T., E, D., & T, A. (2022). Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners.. Clinical and experimental rheumatology. https://doi.org/10.55563/clinexprheumatol/qq9qup

Source records

pubmed · retrieved 2026-09-26T01:48:52.335Z